Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. We have built several drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. We have also built a differentiated pipeline of leading drug candidates. We have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. We are committed to enabling safer, more efficacious and affordable biologics.

Zhuhai Fapon Biopharma Co., Ltd. is a subsidiary of Guangdong Fapon Biopharma Co, Ltd., focusing on generating IL-10M fusion proteins.